Follow
Walter Mier
Walter Mier
University Hospital Heidelberg
Verified email at med.uni-heidelberg.de
Title
Cited by
Cited by
Year
The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis
A Schneider, C Krüger, T Steigleder, D Weber, C Pitzer, R Laage, ...
The Journal of clinical investigation 115 (8), 2083-2098, 2005
8422005
68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
M Eder, M Schäfer, U Bauder-Wüst, WE Hull, C Wängler, W Mier, ...
Bioconjugate chemistry 23 (4), 688-697, 2012
8242012
Phenolic compounds and squalene in olive oils: the concentration and antioxidant potential of total phenols, simple phenols, secoiridoids, lignansand squalene
RW Owen, W Mier, A Giacosa, WE Hull, B Spiegelhalder, H Bartsch
Food and Chemical Toxicology 38 (8), 647-659, 2000
7512000
68Ga-FAPI PET/CT: tracer uptake in 28 different kinds of cancer
C Kratochwil, P Flechsig, T Lindner, L Abderrahim, A Altmann, W Mier, ...
Journal of Nuclear Medicine 60 (6), 801-805, 2019
6352019
PSMA-targeted radionuclide therapy of metastatic castration-resistant prostate cancer with 177Lu-labeled PSMA-617
C Kratochwil, FL Giesel, M Stefanova, M Benešová, M Bronzel, ...
Journal of Nuclear Medicine 57 (8), 1170-1176, 2016
5232016
Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy
A Bierhaus, T Fleming, S Stoyanov, A Leffler, A Babes, C Neacsu, ...
Nature medicine 18 (6), 926-933, 2012
4882012
Preclinical evaluation of a tailor-made DOTA-conjugated PSMA inhibitor with optimized linker moiety for imaging and endoradiotherapy of prostate cancer
M Benešová, M Schäfer, U Bauder-Wüst, A Afshar-Oromieh, C Kratochwil, ...
Journal of Nuclear Medicine 56 (6), 914-920, 2015
4782015
Betulinic acid triggers CD95 (APO-1/Fas)-and p53-independent apoptosis via activation of caspases in neuroectodermal tumors
S Fulda, C Friesen, M Los, C Scaffidi, W Mier, M Benedict, G Nuñez, ...
Cancer research 57 (21), 4956-4964, 1997
4711997
Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients
A Afshar-Oromieh, T Holland-Letz, FL Giesel, C Kratochwil, W Mier, ...
European journal of nuclear medicine and molecular imaging 44, 1258-1268, 2017
4652017
F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients
FL Giesel, B Hadaschik, J Cardinale, J Radtke, M Vinsensia, W Lehnert, ...
European journal of nuclear medicine and molecular imaging 44, 678-688, 2017
4582017
Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein
J Petersen, M Dandri, W Mier, M Lütgehetmann, T Volz, F Von Weizsäcker, ...
Nature biotechnology 26 (3), 335-341, 2008
4262008
Isolation, structure elucidation and antioxidant potential of the major phenolic and flavonoid compounds in brined olive drupes
RW Owen, R Haubner, W Mier, A Giacosa, WE Hull, B Spiegelhalder, ...
Food and Chemical Toxicology 41 (5), 703-717, 2003
4102003
Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein
T Lindner, A Loktev, A Altmann, F Giesel, C Kratochwil, J Debus, D Jäger, ...
Journal of Nuclear Medicine 59 (9), 1415-1422, 2018
3912018
Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy
CM Zechmann, A Afshar-Oromieh, T Armor, JB Stubbs, W Mier, ...
European journal of nuclear medicine and molecular imaging 41, 1280-1292, 2014
3732014
The theranostic PSMA ligand PSMA-617 in the diagnosis of prostate cancer by PET/CT: biodistribution in humans, radiation dosimetry, and first evaluation of tumor lesions
A Afshar-Oromieh, H Hetzheim, C Kratochwil, M Benesova, M Eder, ...
Journal of Nuclear Medicine 56 (11), 1697-1705, 2015
3612015
68Ga-FAPI PET/CT: biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAP-targeting agents in patients with various cancers
FL Giesel, C Kratochwil, T Lindner, MM Marschalek, A Loktev, W Lehnert, ...
Journal of Nuclear Medicine 60 (3), 386-392, 2019
3602019
A tumor-imaging method targeting cancer-associated fibroblasts
A Loktev, T Lindner, W Mier, J Debus, A Altmann, D Jäger, F Giesel, ...
Journal of Nuclear Medicine 59 (9), 1423-1429, 2018
3572018
Identification of lignans as major components in the phenolic fraction of olive oil
RW Owen, W Mier, A Giacosa, WE Hull, B Spiegelhalder, H Bartsch
Clinical Chemistry 46 (7), 976-988, 2000
3532000
213Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience
C Kratochwil, FL Giesel, F Bruchertseifer, W Mier, C Apostolidis, R Boll, ...
European journal of nuclear medicine and molecular imaging 41, 2106-2119, 2014
3342014
Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor
S Nkongolo, Y Ni, FA Lempp, C Kaufman, T Lindner, K Esser-Nobis, ...
Journal of hepatology 60 (4), 723-731, 2014
2562014
The system can't perform the operation now. Try again later.
Articles 1–20